Background. To better understand the high incidence of pneumococcal meningitis in the African meningitis belt, we conducted a pneumococcal seroprevalence study during a meningococcal meningitis epidemic in Western Burkina Faso, March 2006.
The African meningitis belt extends from Senegal in the West to Ethiopia in the East with an estimated population of 500 million [1] . The epidemiology of bacterial meningitis in this region is characterized by regular seasonal and sporadic epidemic incidence increases. Although these epidemics are caused by Neisseria meningitis [2] , Streptococcus pneumoniae also contributes to the seasonal peaks [3] . Pneumococcal meningitis in this area causes high burden of disease with a 0.6% lifetime risk, approximately 50% case fatality [4] , and 25% of survivors with documented major sequelae [5] . As in other parts of the developing world, serotype 1 is responsible for the majority of cases, with up to 60% among the population aged 5 years or older [3] .
With support from the GAVI Alliance, many countries in the meningitis belt have introduced or will introduce serotype 1-containing pneumococcal conjugate vaccines (PCV) over the next few years. Given remaining questions about the effectiveness of the serotype 1 valence in West Africa [6] and to identify optimal vaccination schedules, it will be important to document the epidemiology of and natural immunity against pneumococcal infection before vaccine introduction.
To date, no pneumococcal seroprevalence data to our knowledge have been published specifically for the meningitis belt, and we only recently published pneumococcal carriage data for the first time [3] . Evidence also is missing on the extent to which meningococcal and pneumococcal epidemiologies affect each other in this region. Using the opportunity of a meningococcal carriage and seroprevalence study during a meningitis epidemic due to meningococcal serogroup A, we thus aimed to evaluate the serotype-specific pneumococcal seroprevalence in the general population of Burkina Faso and to describe the background of pneumococcal carriage and meningitis incidence.
METHODS
The rural zone of the health district Secteur 15 close to BoboDioulasso in Western Burkina Faso experienced an NmA epidemic during February and March 2006. We selected 3 villages that referred patients to health centers in Lena and Kofila, as described elsewhere [7] , with a total population of 8900 inhabitants. The study was approved by the Ethics Committee of Centre Muraz, Bobo-Dioulasso, Burkina Faso. Six-hundred twenty-four participants in age groups 1-4, 5-9, 10-19, 20-29, and 30-39 years were randomly selected by a 2-stage cluster sampling procedure. After written informed consent by the participant (or the legal guardian for those aged <18 years), we used standard questionnaires to collect information on sociodemographic and vaccination status, clinical history, personal and family medical history, and living conditions. For <10-year-old children, we measured mid-upper arm circumference (MUAC) and height. Malnutrition was defined as MUAC-for-height below 2 standard deviations [8] .
From each participant, a 2-5 mL blood sample was taken, allowed to clot then centrifuged and aliquoted on site, and stored at 8°C for up to 3 hours until freezing at −80°C at Centre Muraz. Serotype-specific immunoglobulin G (IgG) concentrations for serotypes 1, 4, 5, 6B, 9V, 14, 18C, 19F, and 23F were determined at HPA Manchester using a multiplex bead-based assay as described elsewhere [9] . This assay has been validated against the third-generation, internationally recognized enzyme-linked immunosorbent assay [10] and includes adsorption of sera with serotype 22F polysaccharide and CPS. All serotype-specific capsular polysaccharides were obtained from the ATCC or LGC Promochem; CPS was obtained from the Statens Serum Institut, Copenhagen, Denmark.
For carriage evaluation, we used a methodology that previously has demonstrated high pneumococcal carriage prevalence [3] .
Ear, nose, and throat (ENT) specialist nurses used cotton-tipped sterile swabs to collect 2 samples from the posterior pharyngeal wall of each participant. Swabs for pneumococcal isolation were streaked immediately onto plates with sheep blood agar containing 7% gentamycin, and swabs for meningococcal isolation on plates containing vancomycin. The plates were placed immediately in a 5%-CO2 incubator at 37°C (located in a mobile microbiological laboratory), until transport 6-8 hours later to the local reference laboratory at Centre Muraz in Bobo-Dioulasso for further incubation. From each incubated plate with colonies suspicious for S. pneumoniae by aspect (beta-hemolysis, umbilicated), up to 3 bacterial colonies were selected from well-demarcated locations on the plate and submitted to optochine, Gram stain, and catalase testing. Colonies with optochine diameter ≥14 mm or optochine diameter 8-13 mm and positive bile solubility were considered pneumococci. Isolates were subcultured and prepared for transport on Portagerm AMIES agar swabs (Biomérieux) or storage on brain-heart-infusion and 30% glycerol at −80°C. Serotyping was performed using the Pneumotest-latex Kit (Statens Serum Institute) [11] . Meningococcal carriage was identified as reported elsewhere [7] .
Concurrently with the seroprevalence study, cerebrospinal fluid (CSF) samples from all patients presenting with suspected meningitis at the 2 healthcare centers of the study area (Lena and Kofila) [7] were analyzed by polymerase chain reaction (PCR) amplification of the lytA gene for S. pneumoniae [12, 13] .
Statistical Analyses
Data were analyzed with STATA Software 11.0, using standard epidemiological methods, accounting for design effect and stratifying by the sampling age groups. For each serotype and age group, we calculated geometric mean IgG concentrations and the proportion of participants with IgG concentrations that are putatively protective against invasive pneumococcal disease (≥0.35 µg/mL [14] ), along with 95% confidence intervals (95% CI). We also estimated the prevalence of titers ≥1.00 µg/mL, a cutoff previously used in a UK pneumococcal seroprevalence study [15] . We used bivariate and multivariate logistic regression to evaluate determinants of serotype-specific IgG concentrations ≥0.35 µg/mL. Variables were included in a full model if they showed an age-adjusted association with IgG concentration ≥0.35 µg/mL at P < .3, or if they informed on homologous pneumococcal carriage. Using stepwise backward selection, we obtained a parsimonious model for each serotype, until only variables contributing at P < .05 remained. Seven participants reporting recent use of antibiotics were excluded from the carriage analyses.
RESULTS
We included 624 participants, of which 622 had an adequate serum sample for serological analyses. The geometric means and seroprevalence of antibody against pneumococci increased gradually with age ( Figure 1A-C) . Serotype-specific seroprevalence of IgG concentrations ≥0.35 µg/mL (≥1 µg/mL) was around 20% (10%), among 1-to 4-years-olds, and increased to 70% (40%) among 20-to 39-year-olds. Seroprevalence of IgG ≥ 0.35 µg/mL against serotype 1 was up to 71%, and of IgG ≥ 1 µg/mL up to 34% (both among 10-to 14-year-old persons). The age-dependent increase in geometric mean IgG concentrations was most pronounced for serotypes 14, 19A, and 19F .
During age-adjusted analyses, IgG concentrations ≥0.35 µg/ mL against serotype 1 were positively associated with female sex, village of residence, and having received meningococcal A/C polysaccharide vaccine during a recent mass campaign (Table 1) . In multivariate analyses with adjustment for age and other variables, serotype-specific IgG concentrations ≥0.35 µg/ mL against serotype 1 were positively associated with older age, female sex, village of residence, and negatively with usual exposure to kitchen smoke for >1 hour per day (Table 2 ). These determinants varied across the different serotypes, but for at least 3 of the 12 evaluated serotypes, we found a significant positive association with older age, female sex, village of residence, sharing the bedroom with >3 persons, and recent meningococcal vaccination; and a negative association with cigarette smoking, cough at ENT exam, and exposure to kitchen smoking for longer than 1 hour per day (Table 2) . Pneumococcal carriage of any serotype was not significantly associated with IgG ≥ 0.35 µg/mL, nor was carriage of a homologous serotype, except for a negative association of serotype 19F [OR 0.16 (95% CI, .03-.87)]. The analyses for IgG ≥ 1 µg/mL yielded N (%); the total number of participants may vary slightly over variables due to missing data.
The P values were obtained in age-standardized regression models analyzing the association between antibody titers ≥0.35 µg/mL and exposure groups for each characteristic (yes vs no, if not indicated otherwise). a Self-reported meningococcal A/C polysaccharide vaccination during the mass campaign conducted in parallel to the study.
b Self-reported during previous 2 months.
c Malnutrition was defined as middle upper arm circumference for height below two standard deviations.
d Observed during the ear-nose-and-throat exam for swabbing.
e Measured only in unvaccinated participants or those vaccinated against A/C meningococci less than 4 days earlier (N = 155).
similar effect sizes, however with less statistical power (data not shown). Five hundred eighty-one participants reporting no recent antibiotic use were included in the carriage study. One hundred pneumococcal isolates from 41 carriers were identified, yielding a pneumococcal carriage prevalence of 6.6% (95% CI, 4.5%-8.6%), without substantial variation by age group. Due to interruption of the cold chain during isolate storage caused by a power failure, only 38 pneumococcal isolates (38% of total) from 26 carriers (63% of total) could be serotyped. From 8 carriers, 2 or 3 isolates were serotyped, and for 5 of them, 2 different serogroups/types were identified in the same swab. Serogroups 1, 3, 4, 10, and nontypable strains represented each 11%-15% of carriers, and 5, 7, 11, 15, 19 (with serotypes 19A and 19F) , and 23 <10%. This corresponded to an estimated carriage prevalence of 1%-1.5% for serogroups 10, 3, 4, and nontypable strains, and 0.5%-1% for serogroups/types 1, 5, 19, and 19F.
During the 8 surveyed weeks (calendar weeks 10-17), health center nurses identified 310 suspected meningitis cases. Of these, 282 had CSF collected, and 167 were analyzed by PCR (54% of suspected cases). Twenty-four CSF (14%) were confirmed for meningococcal serogroup A and one for pneumococcus (serotype unknown).
DISCUSSION
This is the first description of serotype-specific pneumococcal seroprevalence in the general population of the African meningitis belt, an area known for high burden of pneumococcal meningitis throughout life. We found that IgG antibody concentrations against 12 pneumococcal serotypes increased with age from childhood to adulthood. Among individuals aged 10 years or older, depending on serotype, 50% to 80% had antibody concentrations that are putatively protective against invasive pneumococcal disease. The concurrently obtained pneumococcal carriage and incidence estimates are limited by various issues: low carriage prevalence (and inability to completely rule out methodological issues as an explanation), incomplete serotyping due to power failure, and short duration and small source population for surveillance. Nevertheless, they suggest that the seroprevalence estimates were not obtained during a period of particularly intensive pneumococcal transmission and disease incidence, in contrast to the ongoing meningococcal epidemic with extraordinarily high meningococcal carriage prevalence [7] .
In most areas of the world, infants tend to have higher pneumococcal meningitis incidence than other age groups. For example, in North America and Europe, young children (including infants) had annual pneumococcal meningitis incidences of approximately 10-20/100 000 population compared to approximately 5/100 000 or less among older children and <1/100 000 among working age adults [16] [17] [18] [19] , a finding presumably due to increasing seroprevalence of putatively protective antibodies. In the meningitis belt, high incidence rates are also observed among infants (50/100 000 per year) but remain relatively high among age groups above 5 years into adulthood, with 5-10 cases per 100 000 per year [3, 4] . Serotype 1 is the single serotype most frequently identified in these older age groups. Given this, one might have expected relatively low seroprevalence against invasive serotypes among adolescent and adult age groups of this population, but the observed ageand serotype-specific antipneumococcal seroprevalence estimates are comparable to values reported from the United Kingdom (UK) [15] and the Netherlands [20] , which were obtained using the same (UK) or comparable (Netherlands) serological methods. Similar to the UK data, we found that geometric mean concentrations and seroprevalence of putatively protective concentrations of most serotypes reached a plateau after age 10 years, whereas for some serotypes this plateau was reached in the age group 20-39 years. It is possible that meningitis cases occur among the population group that does not have putatively protective antibody concentrations (40% in the case of serotype 1), but the comparison with the European seroprevalence data suggests that antibodies in the meningitis belt may not develop optimal protective function. An evaluation of antibody functionality using opsonophagocytosis assays is ongoing on the sera of the presented study to explore this explanation.
In a recent report on meningococcal seroprevalence data for the general population of nearby Bobo-Dioulasso during 2008 [3] , the age-related pattern for meningococcal IgG increase was similar to the pneumococcal IgG concentrations in this study [21] . Although high seroprevalence of putatively protective IgG concentrations (and serum bactericidal titers) was achieved during early adolescence, the concomitant meningococcal meningitis incidence did not decline substantially before age 30. There may be a common hypothetical explanation for high incidence persisting into older age groups: during the dry season, colonizing bacteria from the nasopharynx directly invade the meninges along the olfactory nerve, facilitated by mucosal damage during the persistent low air humidity. This invasion route would bypass the blood system including serum antibodies. Meningitis incidence during the dry season would therefore be a function of bacterial transmission (and its age distribution) and mucosal immunity, and to lesser degree of serum antibody concentrations. Higher serum antibody concentrations than 0.35 µg/mL appear to be required to obtain indirect protection against invasive pneumococcal disease through reduction of nasopharyngeal infection, including possibly other types of antibodies [22] , which would agree with the observed historically high meningitis incidence despite high seroprevalence.
In the absence of pneumococcal vaccination, the observed IgG antibody should have been induced by natural contact with [3] , serotypes 12A/F and 25F are missing, whereas 7F was of little relevance in carriage and meningitis in Burkina Faso (Figure 2 ). Little is reported in the international literature about determinants of naturally induced pneumococcal antibody in the general population. In general, determinants of seroprevalence in the absence of pneumococcal vaccination should reflect the dynamics of pneumococcal transmission (or circulation of cross-reacting organisms) and the capacity for immune response among different populations. Consequently, our finding that female sex and residence in specific communities were positively associated with putatively protective IgG concentrations could represent higher likelihood of contact with pneumococci, of better immune response among woman. The association of lower antibody titers with cough at the ENT exam may indicate that persons with lower antibody titers are more likely to have respiratory disease (e.g., if pneumococcus is a major etiology, or low pneumococcal immunity indicates general lower immunity), or that antibodies are bound up for immune defense. By contrast, cigarette smoking and exposure to kitchen fire smoke, both associated with less likelihood of putatively protective IgG concentrations against several serotypes, may be factors that directly diminish the immune response against pneumococcus.
The presence of putatively protective IgG concentrations against serotypes 3, 4, and 7F was strongly and independently associated with recent meningococcal vaccination. As a response to the epidemic, a mass campaign using polysaccharide vaccine against serogroups A and C occurred during our study among the 2-to 30-year-old population [7] . Given that meningococcal serogroup A carriage also was strongly associated with IgG against 7F, we formulate the hypothesis that serogroup A meningococci can cross-react with pneumococcal IgG response against serotype 7F. Serotype 7F is a high-molecular-weight neutral polymer composed of 2-acetamido-2-deoxy-D-galactose, 2-acetamido-2-deoxy-D-glucose, D-glucose, D-galactose, Lrhamnose, and 2-O-acetyl-L-rhamnose residues [23] , which may provide the potential for cross-reactions with serogroup A polysaccharide, which is a homopolymer of 2-acetamindo-2-deoxymannopyranosyl phosphate [24] . This may explain the high seroprevalence of IgG against 7F, a serotype that usually is rarely carried and hypervirulent. Overall, the results of this exploratory analysis of determinants of pneumococcal immunity need to be interpreted with caution, as the multiple testing on different 12 serotypes implies an increased probability of chance findings. The pneumococcal carriage prevalence observed in this study was low compared to other reports in the literature [25] and to the aforementioned carriage study in neighboring Bobo-Dioulasso during 2008 [3] . This study used the same techniques and found 25% prevalence on average over the same age range.
In the present analysis, we have used an IgG concentration of 0.35 µg/mL as a correlate of natural protection against invasive disease for all serotypes, following the World Health Organization (WHO) recommendation for vaccine evaluation in infants [14] . This approach likely is simplistic, as data from vaccine trials in sub-Saharan Africa and Europe suggest these correlates for vaccine protection vary across serotypes and populations [26] [27] [28] and may not apply to older age groups.
Although nasopharyngeal swabs are the standard method for evaluation of pneumococcal carriage [29] , the use of oropharyngeal swabs alone probably does not explain this difference, as we found in 2008 that among older children and adults, swabbing via the nose yielded 30% lower prevalence compared to swabbing via the mouth. The concurrent meningococcal epidemic could have influenced pneumococcal carriage prevalence, especially as serogroup A and Y meningococci were carried in the population at exceptionally high prevalence Figure 2 . Synopsis of carriage and meningitis incidence due to 12 selected pneumococcal serotypes in Bobo-Dioulasso, Western Burkina Faso, 2007-2009 ( previously published in [3] ). The serotypes have been selected for presentation in accordance to the available seroprevalence data. (A) Age-specific carriage prevalence as obtained by nasopharyngeal swabbing among 519 healthy participants aged 1 to 39 years old. Pneumococci were isolated by culture and serotyped by Quellung reaction. (B) Age-specific meningitis annual incidence estimated by active health center-based surveillance among a population of up to 0.9 million inhabitants (no age restriction). Suspected cases of acute bacterial meningitis were confirmed by lytA PCR on cerebrospinal fluid and serotyped by multiplex PCR. Abbreviation: PCR, polymerase chain reaction. [7] . Little is known about interspecies competition between pneumococci and meningococci, but one would expect in this case a negative statistical association between pneumococci and meningococcal carriage or seroprevalence, which we did not find. A final interpretation of this low carriage prevalence is therefore not possible.
In conclusion, this study provides insight into natural pneumococcal seroprevalence in the African meningitis belt and suggests that the protective effect of natural antibody against pneumococcal infection in this population differs from that observed in Europe. These data also will facilitate the interpretation of region-specific data on immunogenicity and vaccine failure during upcoming PCV introduction in the meningitis belt.
Notes

